临床多重耐药大肠埃希菌磷霉素体外敏感性研究  

Investigation of sensitivity to clinical multiresistant Escherichia coli of fosfomycin.

作　　者：陆桃红[1] 田凤喜[1] 高灵宝[1] 朱晓丽[1] 陈亚宝[1] 

机构地区：[1]江苏省泰州市人民医院检验科,江苏泰州225300

出　　处：《海南医学》2009年第7期17-18,135,共3页Hainan Medical Journal

摘　　要：目的评价磷霉素对多重耐药大肠埃希菌的体外药敏效应。方法应用K-B法对临床分离出的24株多重耐药菌进行磷霉素和亚胺培南(泰能)、头孢哌酮/舒巴坦(舒普深)体外药敏实验。结果多重耐药大肠杆菌对磷霉素、亚胺培南和舒谱深的敏感率分别为91.7%、95.8%、95.8%。结论磷霉素可以成为治疗临床多重耐药大肠杆菌感染的一种选择。Objective To evaluate the drug sensitive effect of fosfomycin on clinical multiresistant Escherichia coli in vitro. Methods Drug sensitive experiment of fosfomycin, imipenem and SBT/CPZ were performed to 24 strains clinical multiesistant Escherichia coli by K - B. Results The sensitiveness of fosfomycin, imipenem and SBT/CPZ to clinical muhiresistant Escherichia coli were 91.7% ,95.8% ,95.8%. Conclusion Fosfomyein may be a choice to treat clinical infect with multiresistant Escherichia coli.

关 键 词：磷霉素 多重耐药大肠埃希菌 亚胺培南 舒普深 

分 类 号：R446.5[医药卫生—诊断学]